Restoring America

Conservative values, National renewal

Beltway Confidential

With new Alzheimer’s drug, Biden FDA is not following the science

By Henry Miller
Published
Add Washington Examiner on Google
With new Alzheimer’s drug, Biden FDA is not following the science

Opinion
With new Alzheimer’s drug, Biden FDA is not following the science
By
Henry Miller
January 04, 2023 06:00 AM

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

Alzheimer's Biden Administration FDA Regulations Science